MedPath

Red Cell Storage Duration Study

Phase 3
Completed
Conditions
Cardiac Surgery
Erythrocyte Transfusion
Interventions
Biological: Red blood cell units stored <= 10 days
Biological: Red blood cell units stored >= 21 days
Registration Number
NCT00991341
Lead Sponsor
Carelon Research
Brief Summary

The RECESS study will compare the effects of transfusing red blood cell units stored \<= 10 days vs. red blood cell units stored \>= 21 days, in patients who are undergoing complex cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis is that there is a clinically important difference between the effects of shorter-storage red cell units and longer-storage red cell units on clinical outcomes and mortality risk.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1481
Inclusion Criteria
  • >= 12 years old
  • >= 40 kg body weight
  • Scheduled complex cardiac surgery with planned use of median sternotomy.
  • Patients ≥ 18 years must have a Transfusion Risk Understanding Scoring Tool (TRUST) probability score ≥ 3
Exclusion Criteria
  • Refusal of blood products
  • Planned surgery is minimally invasive
  • Known transfusion reaction history
  • Requirement for washed products, volume reduced products, or products with additive solution removed
  • Expected residual cyanosis with O2 saturation < 90
  • Left ventricular assist device (LVAD) or Extracorporeal membrane oxygenation (ECMO) support pre-operatively or planned need post-operatively
  • Cardiogenic shock requiring pre-operative placement of an Intra-aortic balloon pump (IABP) (IABP done for unstable angina or prophylactically for low ejection fraction is not excluded)
  • Planned Deep Hypothermic Circulatory Arrest (DHCA)
  • Renal dysfunction requiring pre-operative renal replacement therapies such as hemodialysis (HD) or continuous venovenous hemofiltration (CVVH)
  • Planned use of alternative to heparin, e.g. bivalirudin
  • Planned use of autologous or directed donations
  • Prior RBC transfusion during hospitalization for the study-qualifying surgery
  • Prior randomization into the RECESS study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Shorter-storage red blood cell unitsRed blood cell units stored <= 10 daysRed blood cell units stored \<= 10 days
Longer-storage red blood cell unitsRed blood cell units stored >= 21 daysRed blood cell units stored \>= 21 days
Primary Outcome Measures
NameTimeMethod
The Change in the Composite Multiple Organ Dysfunction Score (MODS) From the Pre-operative Baseline. The Worst Post-operative Values of Each Component of MODS Will be Used to Calculate the Change in MODS.Through post-operative day 7, hospital discharge, or death, whichever occurs first

The follow-up MODS used to calculate 7-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 7, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored \[subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation\], then a post-op MODS score was set to missing and a 7-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).

Secondary Outcome Measures
NameTimeMethod
Composite of Major In-hospital Post-operative Complications (Death, Stroke, Myocardial Infarction, Renal Failure, Culture-proven Sepsis/Septic Shock)Through post-operative day 7, hospital discharge, or death, whichever occurs first
Change in Serum Creatinine From Pre-operative Value to Worst Post-operative ValueThrough post-operative day 7, hospital discharge, or death, whichever occurs first
Change in Lactate From Pre-operative Value to Worst Post-operative ValueThrough post-operative day 7, hospital discharge, or death, whichever occurs first

The arterial lactate levels were adjusted to make them comparable to venous lactate levels.

Composite of Major Pulmonary Events (Any Mechanical Ventilation From 48 Hours Post-operation to Day 7, Hospital Discharge or Death, Whichever Comes First, or Pulmonary Embolism)Through post-operative day 7, hospital discharge, or death, whichever occurs first
Ventilation DurationThrough post-operative day 28, hospital discharge, or death, whichever occurs first

Because some subjects may experience multiple periods of ventilator use, the total duration that they were on a ventilator was compared between the two groups.

Change in Troponin-I From Pre-operative Value to Worst Post-operative ValueThrough post-operative day 7, hospital discharge, or death, whichever occurs first
Change in Bilirubin From Pre-operative Value to Worst Post-operative ValueThrough post-operative day 7, hospital discharge, or death, whichever occurs first
Composite of Major Cardiac Events (Death, Myocardial Infarction, Low Cardiac Output, Ventricular Tachycardia, Ventricular Fibrillation)Through post-operative day 7, hospital discharge, or death, whichever occurs first
Change in ALT From Pre-operative Value to Worst Post-operative Value (for Pediatric Subjects Only)Through post-operative day 7, hospital discharge, or death, whichever occurs first
Days to First Solid FoodThrough post-operative day 28, hospital discharge, or death, whichever occurs first

Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative solid food.

All-cause Mortality28 days post-surgery

Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed for all-cause mortality until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analysis started at randomization.

Change in Multiple Organ Dysfunction Score From Pre-operative Baseline.Through 28 days post-surgery, hospital discharge, or death, whichever occurs first

The follow-up MODS used to calculate 28-day ΔMODS from pre-op baseline was based on the worst value of each component of MODS observed through post-op day 28, hospital discharge, or death, whichever occurred first, even if a subject's worst values for different components occurred on different dates. Subjects who died during this time period were assigned the worst possible follow-up MODS score, 24 points, and each component of MODS was set at 4, which is the worst score. If a subject did not die during this time period but had at least one day where the Glasgow Coma Score couldn't be scored\[subject sedated; neurologic function not normal by pre-op history (prior stroke, tumor or trauma sequelae, cognitively challenged, behavioral disorder, etc.) or intra-op history, but currently unable to assess because of sedation\], then a post-op MODS score was set to missing and a 28-day ΔMODS was not computed. The total MODS score ranges from 0 (best possible) to 24 points (worst possible).

Days to First Bowel MovementThrough post-operative day 28, hospital discharge, or death, whichever occurs first

Subjects were randomized for RECESS no earlier than one calendar day before the planned date of surgery, and were followed until post-operative Day 28, death, or study withdrawal, whichever occurred first. In some cases the surgery was postponed after randomization had already occurred. If surgery did not occur within 30 days after randomization, the subject ended the study and was not considered evaluable. If surgery did occur within 30 days after randomization, and the subject received at least one RBC transfusion between randomization and 96 hours after the end of surgery, the subject was considered evaluable. Therefore, in a few evaluable subjects, post-operative Day 28 could be nearly two months after the date of randomization. The times in the time-to-event analyses are from randomization to first post-operative bowel movement.

Days Alive and Ventilator Free Through Post-op Day 28Through post-op day 28
Any Mechanical Ventilation More Than 48 Hours Post-operation48 hours post-operation through day 28, hospital discharge, or death, whichever occurs first

Trial Locations

Locations (33)

Emory University

🇺🇸

Atlanta, Georgia, United States

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

University of Maryland

🇺🇸

Baltimore, Maryland, United States

Robert Wood Johnson Medical School

🇺🇸

New Brunswick, New Jersey, United States

Aspirus Vascular Heart Center

🇺🇸

Wausau, Wisconsin, United States

Brigham & Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Children's Hospital Boston

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

UPMC-Mercy Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Texas Heart Institute

🇺🇸

Houston, Texas, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

St. Elizabeth's Medical Center

🇺🇸

Boston, Massachusetts, United States

Fairview Southdale Hospital/University of Minnesota Medical Center Fairview

🇺🇸

Minneapolis, Minnesota, United States

Duke University

🇺🇸

Durham, North Carolina, United States

University of Pittsburgh Presbyterian and Shadyside

🇺🇸

Pittsburgh, Pennsylvania, United States

Veterans Administration Puget Sound

🇺🇸

Seattle, Washington, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Indiana/Ohio Heart

🇺🇸

Fort Wayne, Indiana, United States

St. Joseph Hospital

🇺🇸

Fort Wayne, Indiana, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Newark Beth Israel Deaconess Medical Center

🇺🇸

Newark, New Jersey, United States

Columbia University Health Center

🇺🇸

New York, New York, United States

Weill Cornell Medical School

🇺🇸

New York, New York, United States

University of North Carolina at Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Sanford Heart Center

🇺🇸

Fargo, North Dakota, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

UT Southwestern

🇺🇸

Dallas, Texas, United States

Froedtert Memorial Lutheran Hospital

🇺🇸

Milwaukee, Wisconsin, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

Aurora St. Lukes Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath